Concepedia

Bone Metastases in Patients with Neuroendocrine Tumor: <sup>68</sup>Ga-DOTA-Tyr<sup>3</sup>-Octreotide PET in Comparison to CT and Bone Scintigraphy

Daniel Putzer, Michael Gabriel, Benjamin Henninger, Dorota Kendler, Christian Uprimny, Georg Dobrozemsky, Clemens Decristoforo, Reto Bale, Werner Jaschke, Irene Virgolini

Journal of Nuclear Medicine · 2009 · 215 citations · 28 references

DOIFull text

Open access

Abstract

(68)Ga-DOTATOC PET is a reliable, novel method for the early detection of bone metastases in patients with neuroendocrine tumor. Our results show that CT and conventional bone scintigraphy are less accurate than (68)Ga-DOTATOC PET in the primary staging or restaging of neuroendocrine tumor.

References

28

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

Michael Gabriel, Clemens Decristoforo, Dorota Kendler et al. · Journal of Nuclear Medicine · 2007 · 1K citations · Full text

Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data

Michael Hofmann, Helmut R. Maëcke, A. Börner et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 539 citations

, , +11

Carcinoid tumors: Analysis of prognostic factors and survival in 301 patients from a referral center

Eva Tiensuu Janson, Lars Holmberg, Mats Stridsberg et al. · Annals of Oncology · 1997 · 458 citations

, , +8

Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors

Sanjay Gupta, Marcella M. Johnson, Ravi Murthy et al. · Cancer · 2005 · 429 citations · Full text

Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization

Francesco Panzuto, S. Nasoni, Massimo Falconi et al. · Endocrine Related Cancer · 2005 · 396 citations · Full text